A61K 39/008
Leishmania antigens
A61K39/008 (Leishmania antigens) appears on 110 US grants and 143 published applications in this corpus.
Search patents in A61K- Granted patents
- 110
- Published applications
- 143
- Assignees
- 117
- Inventors
- 267
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 3 |
| 2003 | 2 | 9 |
| 2004 | 3 | 5 |
| 2005 | 3 | 2 |
| 2006 | 0 | 9 |
| 2007 | 3 | 1 |
| 2008 | 4 | 7 |
| 2009 | 1 | 8 |
| 2010 | 3 | 7 |
| 2011 | 3 | 10 |
| 2012 | 3 | 5 |
| 2013 | 8 | 8 |
| 2014 | 11 | 11 |
| 2015 | 5 | 6 |
| 2016 | 3 | 6 |
| 2017 | 2 | 3 |
| 2018 | 8 | 10 |
| 2019 | 4 | 0 |
| 2020 | 3 | 10 |
| 2021 | 5 | 7 |
| 2022 | 3 | 4 |
| 2023 | 4 | 3 |
| 2024 | 1 | 3 |
| 2025 | 6 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Live attenuated Leishmania parasite vaccines with enhanced safety characteristics16 Jun 2026US 12,653,875 B2Ohio State Innovation Foundation
- Anti-parasitic immunological compositions9 Jun 2026US 12,648,993 B2Board of Regents of the University of Nebraska
- Sterols as novel immunomodulatory agents and their use as vaccine adjuvants25 Nov 2025US 12,478,671 B2Ohio State Innovation Foundation
- Use of parasites and extracellular vesicles obtained from parasites in cancer treatment11 Nov 2025US 12,465,623 B2Yeditepe Universitesi
- Use of trimanganese tetraoxide particles in preparation of vaccine adjuvant11 Nov 2025US 12,465,634 B2Guangzhou Realbenefitspot Pharmaceutical Co., Ltd.
- Liposomal formulation for treatment of visceral leishmaniasis24 Sep 2026US 2026/0284167 A1Council of Scientific and Industrial Research
- Live attenuated leishmania parasite vaccines with enhanced safety characteristics17 Sep 2026US 2026/0273036 A1Ohio State Innovation Foundation
- Sterols as novel immunomodulatory agents and their use as vaccine adjuvants26 Feb 2026US 2026/0053912 A1Ohio State Innovation Foundation
- Nanostructured lipid carriers and stable emulsions and uses thereof31 Jul 2025US 2025/0241854 A1Access To Advanced Health Institute
- Dna vaccine against leishmaniasis1 May 2025US 2025/0134979 A1Intervet Inc.
Most cited
By later US patents
- Submicron emulsions as vaccine adjuvants129US 5,961,970 APharmos Corporation · 1999
- Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response90US 6,797,276 B1The United States of America as represented by the Secretary of the Army · 2004
- Compositions and methods for use of IL-12 as an adjuvant75US 5,723,127 AThe Trustees of the University of Pennsylvania · 1998
- Oligodeoxynucleotide and its use to induce an immune response56US 6,977,245 B2The United States of America as represented by the Department of Health and Human Services · 2005
- Compositions and methods for use of IL-12 as an adjuvant44US 5,571,515 AThe Trustees of the University of Pennsylvania · 1996